Global X Genomics & Biotechnology ETF
GNOM
40 hedge funds and large institutions have $14.8M invested in Global X Genomics & Biotechnology ETF in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 17 reducing their positions, and 10 closing their positions.
27% more capital invested
Capital invested by funds: $11.7M → $14.8M (+$3.13M)
4.65% more ownership
Funds ownership: 24.14% → 28.79% (+4.7%)
7% less funds holding
Funds holding: 43 → 40 (-3)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
65% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.53M |
| 2 |
Two Sigma Investments
New York
|
+$777K |
| 3 |
AA
Armis Advisers
Atlanta,
Georgia
|
+$595K |
| 4 |
USCWA
U.S. Capital Wealth Advisors
Austin,
Texas
|
+$561K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$408K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$1.18M |
| 2 |
IA
Insight Advisors
Newtown,
Pennsylvania
|
-$579K |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
-$359K |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
-$254K |
| 5 |
SAM
Smartleaf Asset Management
Boston,
Massachusetts
|
-$215K |
GNOM Hedge Fund Activity: Q4 2025 in Review
40 of the 8,275 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2025, worth a combined $14.8M — up 27% from $11.7M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNOM and 8 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 6 added.
The largest buyer was Bank of America, adding an estimated $1.53M. The largest seller was Flow Traders U.S., cutting an estimated $1.18M.
- 40 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2025, down from 43 in Q3 2025.
- Funds reported $14.8M of Global X Genomics & Biotechnology ETF stock for Q4 2025, up 27% quarter-over-quarter.
- 8 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2025 and 10 closed out, a net change of -2 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2025 was Bank of America, an estimated $1.53M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q4 2025 was Flow Traders U.S., an estimated $1.18M sold.
Based on aggregated 13F filings for Q4 2025.